Valiant Laboratories Limited
Valiant Laboratories Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: VALIANTLAB and BSE: 543998 (ISIN INE0JWS01017).
It has a market capitalisation of ₹764 crore, a last close of ₹140.75 on 2026-10-19, a one-year return of 70.1%.
Valuation: a price-to-earnings ratio of 47.76x, a price-to-book ratio of 2.46x, a dividend yield of 0.0%.
Profitability: return on equity of -1.2%, return on capital employed of 0.8%, an operating margin of 10.9%.
Balance sheet and ownership: debt-to-equity of 0.14x, promoter holding of 74.9%.
| Metric | Value |
|---|---|
| Market capitalisation | 764 |
| Last close | ₹140.75 |
| P/E (TTM) | 47.76x |
| P/B | 2.46x |
| Dividend yield | 0.0% |
| ROE (FY) | -1.2% |
| ROCE (FY) | 0.8% |
| Operating margin (TTM) | 10.9% |
| Debt / equity | 0.14x |
| Promoter holding | 74.9% |
| 1-year return | 70.1% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means